These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 32749001)

  • 1. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
    Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
    Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.
    Liu J; Xia X; Huang P
    Mol Ther; 2020 Nov; 28(11):2358-2366. PubMed ID: 32931751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments.
    Yue J; Yin Y; Feng X; Xu J; Li Y; Li T; Liang S; He X; Liu Z; Wang Y
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
    Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
    Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P; Zhang Y; Zhuang L; Gan B
    Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
    Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM; Knight LJ; Donaldson PJ; Lim JC
    Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus mutagenesis approach improves the thermal stability of system x
    Oda K; Lee Y; Wiriyasermkul P; Tanaka Y; Takemoto M; Yamashita K; Nagamori S; Nishizawa T; Nureki O
    Protein Sci; 2020 Dec; 29(12):2398-2407. PubMed ID: 33016372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. System Xc
    Liu MR; Zhu WT; Pei DS
    Invest New Drugs; 2021 Aug; 39(4):1123-1131. PubMed ID: 33506324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
    Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
    Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
    Banerjee S; Sarkar R; Mukherjee A; Mitra S; Gope A; Chawla-Sarkar M
    Virus Res; 2024 Jan; 339():199261. PubMed ID: 37923170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
    Wang F; Yang Y
    Breast Cancer Res Treat; 2014 Aug; 147(1):203-10. PubMed ID: 25085754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture Inhibits Neural Ferroptosis in Rat Model of Traumatic Brain Injury
    Li N; Wang R; Ai X; Guo J; Bai Y; Guo X; Zhang R; Du X; Chen J; Li H
    Curr Neurovasc Res; 2024; 21(1):86-100. PubMed ID: 38629369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.